Immunome Q1 EPS $(0.48) Beats $(0.57) Estimate
Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.57) by 15.79 percent. This is a 7.69 percent increase over losses of $(0.52) per share from the same
